Back to User profile » Dr Mohi Ahsa

Papers published by Dr Mohi Ahsa:


Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability [Retraction]

Rahim H, Sadiq A, Ullah R, Bari A, Amin F, Farooq U, Ullah Jan N, Mahmood HM

International Journal of Nanomedicine 2023, 18:7711-7712

Published Date: 15 December 2023

RETRACTED ARTICLE: Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability

Rahim H, Sadiq A, Ullah R, Bari A, Amin F, Farooq U, Ullah Jan N, Mahmood HM

International Journal of Nanomedicine 2020, 15:8999-9009

Published Date: 17 November 2020

Comparative Cholinesterase, α-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives

Ahmad A, Ullah F, Sadiq A, Ayaz M, Saeed Jan M, Shahid M, Wadood A, Mahmood F, Rashid U, Ullah R, Sahibzada MUK, Alqahtani AS, Mahmood HM

Drug Design, Development and Therapy 2020, 14:2165-2178

Published Date: 3 June 2020

Pharmacological Evaluation of Aldehydic-Pyrrolidinedione Against HCT-116, MDA-MB231, NIH/3T3, MCF-7 Cancer Cell Lines, Antioxidant and Enzyme Inhibition Studies

Ahmad A, Ullah F, Sadiq A, Ayaz M, Rahim H, Rashid U, Ahmad S, Jan MS, Ullah R, Shahat AA, Mahmood HM

Drug Design, Development and Therapy 2019, 13:4185-4194

Published Date: 10 December 2019

Enzyme Inhibitory, Antioxidant And Antibacterial Potentials Of Synthetic Symmetrical And Unsymmetrical Thioureas

Naz S, Zahoor M, Umar MN, Ali B, Ullah R, Shahat AA, Mahmood HM, Sahibzada MUK

Drug Design, Development and Therapy 2019, 13:3485-3495

Published Date: 7 October 2019

Isolation, pharmacological evaluation and molecular docking studies of bioactive compounds from Grewia optiva

Ul Bari W, Zahoor M, Zeb A, Sahibzada MUK, Ullah R, Shahat AA, Mahmood HM, Khan I

Drug Design, Development and Therapy 2019, 13:3029-3036

Published Date: 26 August 2019